Catalent Pharma Solutions has acquired Australian pharmaceutical packaging business Pharmapak Technologies for an undisclosed amount.

The acquisition will allow Catalent to improve its ability to offer integrated solutions to customers.

Pharmapak will provide regional packaging capabilities, which will complement Catalent’s existing facility in Braeside, Victoria, where Catalent produces oral dose products, including softgels, and Vegicaps and OptiShell capsules, for supply throughout Asia Pacific.

“This latest investment is in response to strong, local market demand for both pharmaceutical, over-the-counter and complementary medicine products.”

Based in New South Wales, Pharmapak offers primary and secondary packaging of oral pharmaceutical dose forms including blisters, bottles and a wide range of tertiary packaging services.

Catalent Asia Pacific president Mark Bisset said: “This acquisition complements our industry-leading oral dosage form development and manufacturing capabilities with a broader range of packaging options, from bulk supply to finished packs.

“Catalent has made substantial recent investments in Asia Pacific with a new facility in China, and last year we celebrated our 40th year in Japan with a new laboratory and the build-out of more manufacturing capacity. This latest investment is in response to strong, local market demand for both pharmaceutical, over-the-counter (OTC) and complementary medicine products.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Tick here to opt out of curated industry news, reports, and event updates from Packaging Gateway.

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Pharmapak Technologies will continue to operate with the same name and will also retain approximately 100 employees, including its leadership team at its existing facility in Dee Why, New South Wales.

Catalent employs around 8,500 people across 30 facilities. The company generated more than $1.8bn in annual revenues last year.